Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy. (2019)

First Author: Sha C
Attributed to:  Infrastructure for collaboration: Leeds MRC Medical Bioinformatics Centre funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/jco.18.01314

PubMed Identifier: 30523719

Publication URI: http://europepmc.org/abstract/MED/30523719

Type: Journal Article/Review

Volume: 37

Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Issue: 3

ISSN: 0732-183X